ADA example [Bioanalytics]

posted by mittyri  – Russia, 2019-03-18 23:20 (2230 d 07:18 ago) – Posting: # 20047
Views: 6,758

Hi Helmut,

Thank you so much for the detailed answer!

❝ ❝ Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?


❝ Not sure what you mean here.


Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
26 visitors (0 registered, 26 guests [including 6 identified bots]).
Forum time: 07:39 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5